# OnCo record keynote-204 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/keynote-204/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "keynote-204", "NCT02684292" ;
  schema:name "KEYNOTE-204"@en ;
  schema:description "In KEYNOTE-204, PD-1 blockade beat the CD30 ADC head to head in relapsed Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/trials/keynote-204/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02684292> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2016-05-23" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/relapsed-refractory-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/brentuximab-vedotin/> ;
  onco:companies <https://onco.cc/companies/merck/> .